| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-8993(97)00137-6 |
| P698 | PubMed publication ID | 9187327 |
| P2093 | author name string | Liu S | |
| Yezierski RP | |||
| Ruenes GL | |||
| P2860 | cites work | A new type of glutamate receptor linked to inositol phospholipid metabolism | Q28282769 |
| Protective effect of the NMDA antagonist MK-801 on photochemically induced spinal lesions in the rat | Q30997069 | ||
| Excitotoxic cell death | Q34245367 | ||
| Transient spinal ischemia in rat: characterization of spinal cord blood flow, extracellular amino acid release, and concurrent histopathological damage | Q36732406 | ||
| Characterization of photochemically induced spinal cord injury in the rat by light and electron microscopy | Q36752028 | ||
| Pharmacological and functional characteristics of metabotropic excitatory amino acid receptors | Q37566538 | ||
| Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches | Q37576595 | ||
| The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death | Q37585239 | ||
| Excitatory amino acids and synaptic transmission: the evidence for a physiological function | Q37588602 | ||
| Excitatory amino acid neurotoxicity and neurodegenerative disease | Q37989602 | ||
| Glutamate and the pathophysiology of hypoxic--ischemic brain damage | Q38161694 | ||
| The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system | Q38272501 | ||
| The physiology of excitatory amino acids in the vertebrate central nervous system | Q39462515 | ||
| Pain following spinal cord injury: the clinical problem and experimental studies | Q40917755 | ||
| Effect of kynurenate on functional deficits resulting from traumatic spinal cord injury | Q41099555 | ||
| Spinal cord ischemia-induced elevation of amino acids: extracellular measurement with microdialysis | Q41175290 | ||
| Alteration in extracellular amino acids after traumatic spinal cord injury | Q41223676 | ||
| A potential role for excitotoxins in the pathophysiology of spinal cord injury | Q41336337 | ||
| Ionic dependence of glutamate neurotoxicity | Q41343328 | ||
| Neuronal damage following intraspinal injection of a nitric oxide synthase inhibitor in the rat. | Q42522499 | ||
| Effects of NMDA receptor antagonists following spinal ischemia in the rabbit | Q43844073 | ||
| Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury | Q44176716 | ||
| Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage | Q45181343 | ||
| Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones | Q45263360 | ||
| Neuroprotective effect of MK-801 and U-50488H after contusive spinal cord injury | Q46862766 | ||
| The mechanosensitivity of spinal sensory neurons following intraspinal injections of quisqualic acid in the rat. | Q48249793 | ||
| Quisqualic acid-induced neurotoxicity is protected by NMDA and non-NMDA receptor antagonists | Q48443653 | ||
| The metabotropic excitatory amino acid receptor agonist 1S,3R-ACPD selectively potentiates N-methyl-D-aspartate-induced brain injury | Q48480880 | ||
| NBQX, an AMPA antagonist, reduces glutamate-mediated brain edema | Q48525869 | ||
| Quisqualate‐Stimulated Phosphatidylinositol Breakdown in Rat Cerebellar Membranes | Q48545192 | ||
| Glutamate Toxicity: An Experimental and Theoretical Analysis | Q48551781 | ||
| Vascular changes in the spinal cord in N-methyl-D-aspartate-induced excitotoxicity: morphological and permeability studies | Q48581349 | ||
| Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord | Q48722828 | ||
| Neurotoxic effects of excitatory amino acids in the mouse spinal cord: quisqualate and kainate but not N-methyl-D-aspartate induce permanent neural damage | Q48880347 | ||
| 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia | Q49105194 | ||
| The role of excitatory amino acids and NMDA receptors in traumatic brain injury | Q69370501 | ||
| Quisqualate neurotoxicity: a delayed, CNQX-sensitive process triggered by a CNQX-insensitive mechanism in young rat hippocampal slices | Q69371833 | ||
| Calcium dependency of N-methyl-D-aspartate toxicity in slices from the immature rat hippocampus | Q69556030 | ||
| Neuronal degeneration and spinal cavitation following intraspinal injections of quisqualic acid in the rat | Q72333509 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | excitotoxicity | Q901117 |
| P304 | page(s) | 160-167 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord | |
| P478 | volume | 756 |
| Q44893940 | AMPA receptor activation, but not the accumulation of endogenous extracellular glutamate, induces paralysis and motor neuron death in rat spinal cord in vivo. |
| Q37252957 | Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury |
| Q79489612 | Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity |
| Q39174919 | CCR5 blockade promotes M2 macrophage activation and improves locomotor recovery after spinal cord injury in mice |
| Q41093883 | Central Pain from Excitotoxic Spinal Cord Injury Induced by Intraspinal NMDA Injection: A Pilot Study |
| Q40440411 | Comparison of the spinal neuropathic pain induced by intraspinal injection of N-methyl-d-aspartate and quisquate in rats |
| Q44658683 | Conditions affecting the onset, severity, and progression of a spontaneous pain-like behavior after excitotoxic spinal cord injury |
| Q43981146 | DNA microarray analysis of the contused spinal cord: effect of NMDA receptor inhibition |
| Q73058913 | Diffusion-weighted MR imaging in a rat model of syringomyelia after excitotoxic spinal cord injury |
| Q48850105 | Effects of sacrocaudal spinal cord transection and transplantation of fetal spinal tissue on withdrawal reflexes of the tail |
| Q41205010 | Gliopathy ensures persistent inflammation and chronic pain after spinal cord injury |
| Q45116227 | Glutamate and its receptors in the pathophysiology of brain and spinal cord injuries |
| Q48266710 | MicroRNA-155 Deficiency Suppresses Th17 Cell Differentiation and Improves Locomotor Recovery after Spinal Cord Injury |
| Q44567424 | N-methyl-D-aspartate receptor subunit expression and phosphorylation following excitotoxic spinal cord injury in rats |
| Q44753973 | Neuroprotective effects of nicotinamide after experimental spinal cord injury |
| Q73029455 | Neurotoxicity of glutamate at the concentration released upon spinal cord injury |
| Q34581480 | Non-surgical management of spinal cord injury |
| Q44332581 | Opioid peptide messenger RNA expression is increased at spinal and supraspinal levels following excitotoxic spinal cord injury |
| Q42414570 | PI3K mediated activation of GSK-3β reduces at-level primary afferent growth responses associated with excitotoxic spinal cord injury dysesthesias |
| Q34094124 | Pain following spinal cord injury: pathophysiology and central mechanisms |
| Q38234624 | Receptor for advanced glycation end products (RAGE) and its ligands: focus on spinal cord injury |
| Q40767258 | Reduction in expression of the astrocyte glutamate transporter, GLT1, worsens functional and histological outcomes following traumatic spinal cord injury |
| Q48000851 | Retracing your footsteps: developmental insights to spinal network plasticity following injury. |
| Q36056763 | Review of the history and current status of cell-transplant approaches for the management of neuropathic pain |
| Q73930249 | Riluzole improves measures of oxidative stress following traumatic spinal cord injury |
| Q50522867 | Spatial and temporal changes in promoter activity of the astrocyte glutamate transporter GLT1 following traumatic spinal cord injury. |
| Q44262077 | The influence of MK-801 on the hippocampal free arachidonic acid level and Na+,K+-ATPase activity in global cerebral ischemia-exposed rats. |
| Q43664469 | The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury |
Search more.